12 weeks

OTHER6 trials

Sponsors

Kashan University of Medical Sciences, Seiichiro Aoe Otsuma Women's University Faculty of Home Economics Department Food Science, Yakult Honsha Co., Ltd., JW Pharmaceutical, Boehringer Ingelheim

Conditions

Age: between 20 and 59 years old , Body mass index (BMI): above 25 kg/m2 adult men and womenBenign Prostatic HyperplasiaDiabets type 2. Non-insulin-dependent diabetes mellitusHealthy volunteersNASH (niet alcoholische steatose hepatitis) Non alcoholic liver inflammation Non alcoholic steatohepatitisNocturiaNon-alcoholic fatty liver disease Diabetes patient NAFLD DM type II Insulin resistance SGLT2 inhibitor Fatty liver

Phase 2

A multi-centre, double-blind, parallel-group, randomised, placebo controlled phase II a study to investigate safety, tolerability, pharmacodynamics, and harmacokinetics of different doses of orally administered BI 1467335 during a 12-week treatment period compared to placebo in patients with clinical evidence of NASH.

Active, not recruitingNL-OMON47669

Boehringer IngelheimNASH (niet alcoholische steatose hepatitis) Non alcoholic liver inflammation Non alcoholic steatohepatitis

Start: 2019-01-08Target: 2Updated: 2024-02-28

Phase 3

Effect of Morus Alba leaves’s extract supplement on type 2 diabetes

Active, not recruitingIRCT2016081312438N21

Kashan University of Medical SciencesDiabets type 2. Non-insulin-dependent diabetes mellitus

Start: 2016-11-21Target: 60Updated: 2022-05-02

Phase 4

Efficacy and Safety of Silodosin on Nocturia for Patients With Benign Prostatic Hyperplasia

CompletedNCT02106182

JW PharmaceuticalBenign Prostatic Hyperplasia, Nocturia

Start: 2014-01-02End: 2016-08-01Updated: 2017-03-10

The effects of dapagliflozin on hepatic and visceral fat in type 2 diabetes patients with non-alcoholic fatty liver disease

Active, not recruitingTCTR20170511001

The Faculty of Medicine endownment FundNon-alcoholic fatty liver disease Diabetes patient NAFLD DM type II Insulin resistance SGLT2 inhibitor Fatty liver

Start: 2016-12-28Target: 40Updated: 2026-03-30

Unknown Phase

Effect of daily intake of the test food on serum lipid levels and visceral fat accumulation

Active, not recruitingJPRN-UMIN000047577

Seiichiro Aoe Otsuma Women's University Faculty of Home Economics Department Food ScienceAge: between 20 and 59 years old , Body mass index (BMI): above 25 kg/m2 adult men and women

Start: 2022-04-26Target: 44Updated: 2025-11-17

Evaluation of the efficacy and acceptability of a test food in healthy subjects with diarrhea-predominant irritable bowel syndrome-like symptoms

Active, not recruitingJPRN-UMIN000058028

Yakult Honsha Co., Ltd.Healthy volunteers

Start: 2025-06-07Target: 30Updated: 2025-11-17

Related Papers

Morus Alba leaf extract affects metabolic profiles, biomarkers inflammation and oxidative stress in patients with type 2 diabetes mellitus: A double-blind clinical trial.

2022-03-2412 citations